Synthesis and structure–activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3
Authors:
- Jack U. FlanaganJFJack U. Flanagan
- Stephen M.F. JamiesonSJStephen M.F. Jamieson
- Shevan SilvaSSShevan Silva
- Laurent J.M. RigoreauLRLaurent J.M. Rigoreau
- Elisabeth TrivierETElisabeth Trivier
- Tony RaynhamTRTony Raynham
- Andrew P. TurnbullATAndrew P. Turnbull
- William A. DennyWDWilliam A. Denny
- 1 April 2013
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 62, 738-744
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (HE6009/1–1)
This publication has 15 references indexed in Scilit:
- Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3PLOS ONE, 2012
- 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3Journal of Medicinal Chemistry, 2012
- Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based onN-Phenyl-Aminobenzoates and Their Structure–Activity RelationshipsJournal of Medicinal Chemistry, 2012
- Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insightsThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogsChemico-Biological Interactions, 2009
- Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase IsozymesMolecular Pharmacology, 2005
- Crystal Structures of Prostaglandin D2 11-Ketoreductase (AKR1C3) in Complex with the Nonsteroidal Anti-Inflammatory Drugs Flufenamic Acid and IndomethacinCancer Research, 2004
- Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)Molecular and Cellular Endocrinology, 2001
- Structural characterization of substrates for the anion exchange transporter in Caco‐2 cells∥Journal of Pharmaceutical Sciences, 1999
- Comparative anatomy of the aldo–keto reductase superfamilyBiochemical Journal, 1997